Urology Technology Development
The STTR Program is authorized under the same law as the SBIR Program. While both programs have similar goals, the STTR Program also encourages and requires collaboration and technology transfer between small businesses and research institutions. For more information, visit the NIH SBIR/STTR web page.
STTR topics of interest to NIDDK are also listed in the Omnibus Solicitation.
For more information on technology development in urology, or to order a solicitation book, contact Dr. Chris Mullins, Program Director, Urology Basic Cell Biology and Urology Small Business.
Resources for Researchers
Clinical Research
Centers
Funding for Special Communities
NIDDK Staff
- Dr. Kristin Abraham, Cell Signaling and Diabetes Centers Program Director
- Dr. Guillermo Arreaza-Rubin, Director, Clinical Immunology, Type 1 Diabetes Program
- Dr. Terry Bishop, Hematology Research Programs Director
- Dr. Olivier Blondel, Director, Endocrine Systems Biology Program
- Dr. Arthur Castle, Director, Metabolomics and Informatics Programs
- Dr. Robert Karp, Director of the Genetics and Genomics Programs in Digestive Diseases and Nutrition
- Dr. Maren Laughlin, Senior Advisor for Integrative Metabolism
- Dr. Catherine McKeon, Senior Advisor for Genetic Research in Diabetes, Endocrinology and Metabolic Diseases
- Dr. Marva Moxey-Mims, Kidney Centers Program Director; Pediatric Nephrology Program Director; Applied Kidney SBIR Program Director
- Dr. Aaron Pawlyk, Director, Pharmacogenomics and Drug Discovery Program
- Dr. Rebekah Rasooly, Deputy Director of the Division of Kidney, Urologic, and Hematologic Diseases
- Dr. Salvatore Sechi, Proteomic Program Director
- Dr. Jose Serrano, Director of the Liver and Biliary Program; Director of the Pancreas Program
- Dr. Daniel Wright, Hematology Research Programs Director
|
Funding Opportunities
Conferences
Related Study Sections
See Also
|
Page last updated: March 25, 2011